Chronic Myeloid Leukemia Chronic Phase
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia Chronic Phase.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation [Phase 4]
Phase 4 clinical trial of Asciminib in previously treated Indian patients with Philadelphia chromosome–positive chronic myeloid leukemia in …
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors [Phase 2]
Phase 2 clinical trial examining a combination of ruxolitinib and tyrosine kinase inhibitors in chronic myeloid leukemia with reports of tre…
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation [Phase 2]
A pivotal Phase 2 study assessing HQP1351 in patients with chronic myeloid leukemia in chronic phase harboring the T315I mutation.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia [Phase 2]
Phase 2 trial investigating cytochrome P450 inhibition to reduce dasatinib dosage in chronic myeloid leukemia (chronic phase).
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs. [Phase 3]
Phase 3 clinical trial evaluating olverembatinib in chronic myeloid leukemia in chronic phase patients who failed at least two prior second-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluating Omega-3 fatty acid with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia has been …
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase [Phase 4]
Phase 4 real-world study comparing flumatinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase; currently not ye…
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. [Phase 4]
A phase 4 clinical trial evaluating the efficacy and safety of flumatinib in newly diagnosed chronic myeloid leukemia in chronic phase.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Nilotinib for First-line Newly Diagnosed CML-CP Patients [Phase 3]
Phase 3 trial update investigating nilotinib as first-line therapy for newly diagnosed chronic myeloid leukemia in the chronic phase.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure [Phase 4]
Phase 4 clinical trial update for flumatinib in chronic myeloid leukemia in the chronic phase after failure with imatinib.
-
CLINICAL_TRIALS trial_result · 2020-04-22Clinical Trial Update: Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure [Phase 2]
A Phase 2 trial of bosutinib in chronic myeloid leukemia in chronic phase after frontline TKI failure has been terminated; results posted in…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Chronic Myelod Leukemia Registry at Asan Medical Center
The Chronic Myeloid Leukemia Registry at Asan Medical Center has been terminated. The registry covers chronic myeloid leukemia in chronic ph…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log [NA]
This clinical trial update discusses a study on discontinuing imatinib in patients with chronic myeloid leukemia in chronic phase who have s…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Efficacy and Safety of Nilotinib in CML-CP [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of nilotinib in chronic myeloid leukemia, chronic phase.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia [Phase 1]
A Phase 1 study of BMS-354825 (dasatinib) in patients with chronic myeloid leukemia in chronic, accelerated, or blast phases and Philadelphi…